U.S. Markets closed

Pacira Pharmaceuticals, Inc. (PCRX)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
37.20+0.75 (+2.06%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue276,371248,997197,668
Cost of Revenue110,10471,83777,440
Gross Profit166,267177,160120,228
Operating Expenses
Research Development45,67828,66218,731
Selling General and Administrative152,613139,043106,662
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-32,0249,455-5,165
Income from Continuing Operations
Total Other Income/Expenses Net1,241390-100
Earnings Before Interest and Taxes-30,7839,845-5,265
Interest Expense7,0617,7258,278
Income Before Tax-37,8442,120-13,543
Income Tax Expense105264173
Minority Interest---
Net Income From Continuing Ops-37,9491,804-13,716
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-37,9491,856-13,716
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-37,9491,856-13,716